HomeCompareMNILY vs PFE

MNILY vs PFE: Dividend Comparison 2026

MNILY yields 3.16% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MNILY wins by $532.48M in total portfolio value
10 years
MNILY
MNILY
● Live price
3.16%
Share price
$16.00
Annual div
$0.50
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$532.53M
Annual income
$501,966,698.88
Full MNILY calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — MNILY vs PFE

📍 MNILY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMNILYPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MNILY + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MNILY pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MNILY
Annual income on $10K today (after 15% tax)
$268.18/yr
After 10yr DRIP, annual income (after tax)
$426,671,694.05/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, MNILY beats the other by $426,649,374.14/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MNILY + PFE for your $10,000?

MNILY: 50%PFE: 50%
100% PFE50/50100% MNILY
Portfolio after 10yr
$266.29M
Annual income
$250,996,478.80/yr
Blended yield
94.26%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

MNILY
No analyst data
Altman Z
0.8
Piotroski
6/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MNILY buys
0
PFE buys
0
No recent congressional trades found for MNILY or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMNILYPFE
Forward yield3.16%6.13%
Annual dividend / share$0.50$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%13.2%
Portfolio after 10y$532.53M$49.6K
Annual income after 10y$501,966,698.88$26,258.71
Total dividends collected$530.28M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MNILY vs PFE ($10,000, DRIP)

YearMNILY PortfolioMNILY Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$11,331$631.01$9,153$693.39+$2.2KMNILY
2$13,461$1,336.45$8,593$849.25+$4.9KMNILY
3$17,370$2,967.54$8,336$1,066.78+$9.0KMNILY
4$25,744$7,157.92$8,437$1,384.80+$17.3KMNILY
5$47,375$19,829.11$9,013$1,875.40+$38.4KMNILY
6$118,898$68,206.00$10,306$2,680.72+$108.6KMNILY
7$447,176$319,955.03$12,820$4,101.38+$434.4KMNILY
8$2,727,738$2,249,259.78$17,673$6,826.70+$2.71MMNILY
9$28,564,129$25,645,449.41$27,543$12,591.86+$28.54MMNILY
10$532,530,317$501,966,698.88$49,560$26,258.71+$532.48MMNILY

MNILY vs PFE: Complete Analysis 2026

MNILYStock

Minor International Public Company Limited, together with its subsidiaries, operates as a hospitality, restaurant, and lifestyle company in Thailand, China, Australia, and internationally. It operates in four segments: Hotel, Mixed use, Restaurant, and Retail. As of December 31, 2021, the company had approximately 2,389 restaurant outlets in 23 countries under The Pizza Company, The Coffee Club, Riverside, Benihana, Thai Express, Bonchon, Swensen's, Sizzler, Dairy Queen, and Burger King brands. It also invested in, owned, and operated a portfolio of 520 hotels and serviced suites under the Anantara, Avani, Oaks, Tivoli, NH Collection, NH Hotels, nhow, Elewana Collection, Four Seasons, St. Regis, JW Marriott, Radisson Blu, and Minor International brands in 56 countries across the Asia Pacific, the Middle East, Africa, the Indian Ocean, Europe, and the Americas. In addition, the company distributes fashion and lifestyle products under the Anello, Bodum, Bossini, Charles & Keith, Esprit, Joseph Joseph, OVS, Radley, Zwilling J.A. Henckels, and Minor Smart Kids brands through approximately 386 retail points of sale; and provides online shopping and contract manufacturing services. Further, it is involved in the shopping mall, food and beverage sale, spa, supply chain management, distribution, management, vacation club point sale, entertainment, franchise, marketing, consulting, tour operation, asset management, airport lounge, and healthcare businesses; property investment, development, and sales activities; operation of business school; and manufacture and sale of cheese and ice-cream. The company was formerly known as Royal Garden Resorts Plc. and changed its name to Minor International Public Company Limited in 2005. Minor International Public Company Limited was founded in 1978 and is headquartered in Bangkok, Thailand.

Full MNILY Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this MNILY vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MNILY vs SCHDMNILY vs JEPIMNILY vs OMNILY vs KOMNILY vs MAINMNILY vs JNJMNILY vs MRKMNILY vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.